Lacer Drug Patent Portfolio
Lacer owns 2 orange book drugs protected by 2 US patents Given below is the list of Lacer's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8962028 | Topical steroid composition and method | 19 Jun, 2033 | Active |
| US5135943 | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same | 31 May, 2014 | Expired |
Latest Legal Activities on Lacer's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lacer.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 24 Aug, 2022 | US8962028 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Aug, 2018 | US8962028 |
| Application ready for PDX access by participating foreign offices | 31 Aug, 2015 | US8962028 |
| Recordation of Patent Grant Mailed | 24 Feb, 2015 | US8962028 |
| Patent Issue Date Used in PTA Calculation | 24 Feb, 2015 | US8962028 |
| Email Notification | 05 Feb, 2015 | US8962028 |
| Issue Notification Mailed | 04 Feb, 2015 | US8962028 |
| Dispatch to FDC | 22 Jan, 2015 | US8962028 |
| Application Is Considered Ready for Issue | 21 Jan, 2015 | US8962028 |
| Issue Fee Payment Verified | 07 Jan, 2015 | US8962028 |
| Issue Fee Payment Received | 07 Jan, 2015 | US8962028 |
| Response to Reasons for Allowance | 13 Oct, 2014 | US8962028 |
| Electronic Review | 07 Oct, 2014 | US8962028 |
| Email Notification | 07 Oct, 2014 | US8962028 |
| Mail Notice of Allowance | 07 Oct, 2014 | US8962028 |
Lacer's Family Patents
Lacer Drug List
Given below is the complete list of Lacer's drugs and the patents protecting them.
1. Ertaczo
Ertaczo is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5135943 | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same |
31 May, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ertaczo's drug page
2. Ultravate
Ultravate is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8962028 | Topical steroid composition and method |
19 Jun, 2033
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ultravate's drug page